Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01RDB
|
||||
| Former ID |
DNC013343
|
||||
| Drug Name |
N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528720] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H13N5O
|
||||
| Canonical SMILES |
C1=CC=C(C(=C1)C2=NC3=CC=CC=C3N2)C(=O)N=C(N)N
|
||||
| InChI |
1S/C15H13N5O/c16-15(17)20-14(21)10-6-2-1-5-9(10)13-18-11-7-3-4-8-12(11)19-13/h1-8H,(H,18,19)(H4,16,17,20,21)
|
||||
| InChIKey |
FJRZRURKRDCIKZ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium/hydrogen exchanger 1 | Target Info | Inhibitor | [528720] | |
| Pathway Interaction Database | Endothelins | ||||
| RhoA signaling pathway | |||||
| ErbB1 downstream signaling | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| Reactome | Hyaluronan uptake and degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.